Jane Wan

Jane Wan is a freelance writer based in Singapore.


Clinical Trials Head East to Asia

The rising cost of drug development and the decreasing proportion of drug-naive population in the US and European markets are driving international pharmaceutical companies to consider emerging markets as a location to conduct their clinical trials. Asia stands out among the emerging markets given its double-digit growth rates.

Report from Myanmar

Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.

India's Biopharma Industry Valued at $2 Billion

India's biopharmaceutical industry is valued at $2 billion a year with 20 companies producing biosimilars and 50 products available in the domestic market.